Divis Laboratories has said that its facility near Hyderabad has been inspected by the US health regulator for pre-approval of products to be established and sold by the unit, and current good ...

High-level USFDA delegation visits Divi's Labs manufacturing facilities in Hyderabad A delegation from the US Food & Drug Administration (FDA), led by Commissioner Dr Robert M Califf, visited the ...

Hyderabad: Divi's Laboratories registered a 35% jump in consolidated net profit for the second quarter ended September 30, 2025, at 689 crore compared to 510 crore in the corresponding quarter of the ...

Hyderabad-based Divis Laboratories said on Thursday that the US Food and Drugs Administration (USFDA) will lift an import alert imposed on its Unit-II in Visakhapatnam. The announcement led to its ...

The Hyderabad-based company, Divis Laboratories, was allotted 505 acres of land by the Andhra Pradesh government near the coastal town Kakinada. Hyderabad: Police on Tuesday removed dozens of locals ...

Drug-maker Divis Laboratories is likely to post a net profit of around ₹420 crore in the second quarter ended September 30, 2023 as against ₹493 crore earned in the corresponding quarter of the last ...

Divis Laboratories today said its facility near Hyderabad has been inspected by the US health regulator for pre-approval of products to be established and sold by the unit and current good ...